Bernhard Nirit, McAlpine Kristen, Moineddin Rahim, Connolly Bairbre L
Division of Paediatric Medicine, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Canada.
Pediatr Radiol. 2014 Jul;44(7):863-70. doi: 10.1007/s00247-014-2891-6. Epub 2014 Feb 18.
Radiologic insertion of a gastrostomy or gastrojejunostomy tube is a common procedure in children. Glucagon is used to create gastric hypotonia, permitting gastric distension and facilitating percutaneous puncture. Glucagon can cause hyperglycaemia and potentially rebound hypoglycaemia. The safety of glucagon and incidence of hypoglycaemia has not been studied following gastrostomy or gastrojejunostomy tube insertion.
To determine variations in blood glucose in children post gastrostomy or gastrojejunostomy tube insertion. Secondarily, to determine the frequency of hypoglycaemia and hyperglycaemia in children who did or did not receive glucagon.
This is a retrospective observational study of 210 children undergoing percutaneous gastrostomy or gastrojejunostomy tube insertion over a 2-year period. We studied the children's clinical and laboratory parameters. Abnormal blood glucose levels were defined according to age-established norms. We used descriptive statistics and ANOVA.
We analysed 210 children with recorded blood glucose levels. More than 50% of the children were less than the third percentile for weight. In the glucagon group (n = 187) hyperglycaemia occurred in 82.3% and hypoglycaemia in 2.7% (n = 5). In the no glucagon group (n = 23), hyperglycaemia occurred in 43.5% and there were no cases of hypoglycaemia. The peak blood glucose occurred within 2 h, with normalization by 6 h post-procedure. Five children became hypoglycaemic, all received glucagon; 4/5 had weights <3rd percentile. Logistic regression analysis revealed no factors significantly associated with hypoglycaemia.
Greatest blood glucose variability occurs between 1 h and 3 h post-procedure. Hyperglycaemia is common and more severe with glucagon, and hypoglycaemia rarely occurs. These findings have assisted in developing clinical guidelines for post-percutaneous gastrostomy/gastrojejunostomy tube insertion.
经皮插入胃造口管或胃空肠造口管在儿童中是一种常见的操作。胰高血糖素用于使胃张力减退,使胃扩张并便于经皮穿刺。胰高血糖素可导致高血糖,并可能引发反弹性低血糖。胃造口术或胃空肠造口管插入术后,胰高血糖素的安全性及低血糖发生率尚未得到研究。
确定儿童胃造口术或胃空肠造口管插入术后血糖的变化。其次,确定接受或未接受胰高血糖素的儿童中低血糖和高血糖的发生率。
这是一项回顾性观察研究,对2年内接受经皮胃造口术或胃空肠造口管插入术的210名儿童进行了研究。我们研究了儿童的临床和实验室参数。异常血糖水平根据年龄既定标准定义。我们使用了描述性统计和方差分析。
我们分析了210名有血糖水平记录的儿童。超过50%的儿童体重低于第三百分位数。在胰高血糖素组(n = 187)中,82.3%发生高血糖,2.7%(n = 5)发生低血糖。在未使用胰高血糖素组(n = 23)中,43.5%发生高血糖,无低血糖病例。血糖峰值出现在术后2小时内,术后6小时恢复正常。5名儿童发生低血糖,均接受了胰高血糖素治疗;4/5体重低于第三百分位数。逻辑回归分析显示,没有因素与低血糖显著相关。
术后1小时至3小时血糖变化最大。高血糖很常见,使用胰高血糖素时更为严重,低血糖很少发生。这些发现有助于制定经皮胃造口术/胃空肠造口管插入术后的临床指南。